First Manhattan’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,000
Closed -$13K 1653
2021
Q2
$13K Hold
2,000
﹤0.01% 1233
2021
Q1
$13K Buy
+2,000
New +$16.9K ﹤0.01% 1197
2018
Q1
Sell
-300
Closed -$3K 1439
2017
Q4
$3K Hold
300
﹤0.01% 1361
2017
Q3
$5K Buy
+300
New +$6.17K ﹤0.01% 1295

Other funds holding PGEN

First Manhattan's PGEN Position: Q3 2021 in Review

First Manhattan sold out of Precigen (PGEN) in Q3 2021, closing a stake of 2,000 shares — an estimated $13K sold.

First Manhattan first reported a position in PGEN in Q3 2017 and held it in 4 quarters. The position peaked at $13K in Q2 2021. 172 funds tracked by Wall St. Rank hold PGEN as of Q3 2021.

  • First Manhattan reported no remaining Precigen position as of Q3 2021 after selling out during the quarter.
  • First Manhattan sold 2,000 Precigen shares in Q3 2021, an estimated $13K.
  • First Manhattan first reported a position in Precigen in Q3 2017 and held it in 4 quarters.
  • First Manhattan's Precigen position peaked at $13K in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Precigen as of Q3 2021.

Based on First Manhattan's 13F filing for Q3 2021, filed 15 Nov 2021.